{"id":2845,"date":"2020-05-19T06:30:00","date_gmt":"2020-05-19T06:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/xps-saljs-till-en-ledande-lungtransplantationsklinik-i-europa\/"},"modified":"2020-05-19T06:30:00","modified_gmt":"2020-05-19T06:30:00","slug":"xps-saljs-till-en-ledande-lungtransplantationsklinik-i-europa","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-saljs-till-en-ledande-lungtransplantationsklinik-i-europa\/","title":{"rendered":"XPS\u2122 s\u00e4ljs till en ledande lungtransplantationsklinik i Europa"},"content":{"rendered":"
Universitetssjukhuset AKH i Wien, \u00d6sterrike, som \u00e4r en av de tre st\u00f6rsta lungtransplantations-klinikerna i Europa, har k\u00f6pt en XPS\u2122. Leverans och installationen av XPS\u2122 \u00e4r ber\u00e4knad att ske i b\u00f6rjan av juni.<\/strong><\/div>\n

Kliniken i Wien har mer \u00e4n 30 \u00e5rs erfarenhet av lungtransplantation och har ett v\u00e4lrenommerat lungtransplantations-program erk\u00e4nt f\u00f6r att vara ledande inom omr\u00e5det Ex Vivo Lung Perfusion (EVLP). \u00d6sterrike har v\u00e4rldens h\u00f6gsta andel lungtransplantationer per miljon inv\u00e5nare (13,3) enligt Global Observatory on Donation and Transplantation. Wien \u00e4r ett transplantationscenter som utf\u00f6r mer \u00e4n 100 lungtransplantationer per \u00e5r. <\/span><\/span><\/p>\n

AKH University Hospital har tidigare utf\u00f6rt EVLP med den manuella metoden (utan XPS\u2122) och under en tid l\u00e5nat en XPS\u2122. Enligt bolagets aff\u00e4rsmodell \u00e4r priss\u00e4ttningsstrategin f\u00f6r kapitalvaror, det vill s\u00e4ga EVLP-maskinerna LS \u2122 och XPS \u2122, utformad s\u00e5 att denna f\u00f6rs\u00e4ljning inte har n\u00e5gon betydande ekonomisk inverkan p\u00e5 bolaget. Ist\u00e4llet \u00e4r det den framtida f\u00f6rs\u00e4ljning av produkterna som beh\u00f6vs vid anv\u00e4ndningen av EVLP-maskinerna, STEEN Solution \u2122 och medf\u00f6ljande eng\u00e5ngsartiklar, som \u00e4r av ekonomisk betydelse f\u00f6r bolaget.<\/span><\/span><\/p>\n

\u201dBolaget ser det som positivt att Universitetssjukhuset AKH i Wien har k\u00f6pt en XPS\u2122 eftersom kliniken i Wien ligger i framkant n\u00e4r det g\u00e4ller att utvidga anv\u00e4ndningen av donerade lungor och har historiskt utf\u00f6rt banbrytande vetenskap inom detta omr\u00e5de,\u201d s\u00e4ger Dr Magnus Nilsson, VD p\u00e5 XVIVO Perfusion AB.<\/span><\/span><\/p>\n

\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><\/p>\n

G\u00f6teborg 19 maj 2020<\/span><\/span>
\nXVIVO Perfusion AB (publ)<\/span><\/span>
\nMagnus Nilsson , VD<\/span><\/span><\/span><\/p>\n

\n

F\u00f6r ytterligare information, v\u00e4nligen kontakta: <\/span><\/span><\/p>\n

Christoffer Rosenblad, CFO, +46 735 192159, christoffer.rosenblad@xvivoperfusion.com
\nMagnus Nilsson, VD, +46 31-788 21 50, magnus.nilsson@xvivoperfusion.com<\/span><\/span><\/p>\n

F\u00f6r ytterligare information om XVIVO Perfusions verksamhet h\u00e4nvisas till bolagets hemsida, www.xvivoperfusion.com<\/span><\/span><\/p>\n

Informationen l\u00e4mnades, genom ovanst\u00e5ende kontaktpersons f\u00f6rsorg, f\u00f6r offentligg\u00f6rande klockan 8:30 den 19 maj 2020.<\/span><\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Universitetssjukhuset AKH i Wien, \u00d6sterrike, som \u00e4r en av de tre st\u00f6rsta lungtransplantations-klinikerna i Europa, har k\u00f6pt en XPS\u2122. Leverans…<\/p>\n","protected":false},"template":"","class_list":["post-2845","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other"],"acf":[],"yoast_head":"\nXPS\u2122 s\u00e4ljs till en ledande lungtransplantationsklinik i Europa - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-saljs-till-en-ledande-lungtransplantationsklinik-i-europa\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"XPS\u2122 s\u00e4ljs till en ledande lungtransplantationsklinik i Europa - XVIVO\" \/>\n<meta property=\"og:description\" content=\"Universitetssjukhuset AKH i Wien, \u00d6sterrike, som \u00e4r en av de tre st\u00f6rsta lungtransplantations-klinikerna i Europa, har k\u00f6pt en XPS\u2122. Leverans...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-saljs-till-en-ledande-lungtransplantationsklinik-i-europa\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-saljs-till-en-ledande-lungtransplantationsklinik-i-europa\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-saljs-till-en-ledande-lungtransplantationsklinik-i-europa\\\/\",\"name\":\"XPS\u2122 s\u00e4ljs till en ledande lungtransplantationsklinik i Europa - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2020-05-19T06:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-saljs-till-en-ledande-lungtransplantationsklinik-i-europa\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-saljs-till-en-ledande-lungtransplantationsklinik-i-europa\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-saljs-till-en-ledande-lungtransplantationsklinik-i-europa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"XPS\u2122 s\u00e4ljs till en ledande lungtransplantationsklinik i Europa\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"XPS\u2122 s\u00e4ljs till en ledande lungtransplantationsklinik i Europa - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-saljs-till-en-ledande-lungtransplantationsklinik-i-europa\/","og_locale":"en_US","og_type":"article","og_title":"XPS\u2122 s\u00e4ljs till en ledande lungtransplantationsklinik i Europa - XVIVO","og_description":"Universitetssjukhuset AKH i Wien, \u00d6sterrike, som \u00e4r en av de tre st\u00f6rsta lungtransplantations-klinikerna i Europa, har k\u00f6pt en XPS\u2122. Leverans...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-saljs-till-en-ledande-lungtransplantationsklinik-i-europa\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-saljs-till-en-ledande-lungtransplantationsklinik-i-europa\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-saljs-till-en-ledande-lungtransplantationsklinik-i-europa\/","name":"XPS\u2122 s\u00e4ljs till en ledande lungtransplantationsklinik i Europa - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2020-05-19T06:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-saljs-till-en-ledande-lungtransplantationsklinik-i-europa\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-saljs-till-en-ledande-lungtransplantationsklinik-i-europa\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-saljs-till-en-ledande-lungtransplantationsklinik-i-europa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"XPS\u2122 s\u00e4ljs till en ledande lungtransplantationsklinik i Europa"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2845","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2845"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}